The CDC has issued a clinical reminder that insulin pens should never be used for more than one person. In the reminder, the CDC says it has become “increasingly aware of reports of improper use of ...
Dr. Cook answers the question: 'Pros of Giving Insulin By Pen/Syringe?' — -- Question:What are the pros and cons of giving insulin by syringe and by pen? Answer:Well the pen-versus-syringe ...
A new survey, published in The Joint Commission Journal on Quality and Patient Safety, examined insulin pen use in the inpatient setting. Insulin pens can offer several advantages, but there have also ...
Add Yahoo as a preferred source to see more of our stories on Google. Medtronic said Monday it received 510(k) clearance from the Food and Drug Administration for an app to connect its smart insulin ...
Please provide your email address to receive an email when new articles are posted on . A U.S. hospital reduced insulin pen waste by 18.3% after bolstering education efforts and medical alerts. Costs ...
CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those insulin prescriptions. The ...
Due to continuing patient safety problems, ISMP suggests hospitals stop using insulin pens in an inpatient setting, as they were originally intended for ambulatory care. “Other problems such as using ...
NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, ‌Medicaid ...
Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...
The "Insulin Pens Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The insulin pens market is expected to grow at a CAGR of 6.26% during the ...
Ottawa, Feb. 02, 2026 (GLOBE NEWSWIRE) -- The global smart insulin pens market size is calculated at USD 1.02 billion in 2026 and is expected to reach around USD 2.42 billion by 2034, growing at a ...